About Dr. Subhash Gupta

About Dr. Subhash Gupta

MBBS, MS ( AIIMS ), FRCS ( Edin ), FRCS ( Glas )

Chief Liver Transplant / HPB Surgeon Chairman

CLBS, Max Super Speciality Hospital, Saket

E-mail: livertransplant@gmail.com

Tel: +91 9811075683

Publications of Dr. Subhash Gupta

Dr Subhash Gupta has pioneered Liver Transplantation in the Indian subcontinent. It is largely due to his efforts over the last decade that this specialty has become well-established in this part of the world. Liver Transplantation today has given a fresh lease of life to thousands of patients with liver disease.

Dr Gupta was born in the quiet town of Asansol in West Bengal, eastern India. He spent his childhood there and began an academically brilliant career at the St Patrick’s School, Asansol.

After school, he joined the All India Institute of Medical Sciences ( AIIMS ), Delhi, where he obtained his medical degree. He also trained in General Surgery at the same institute before joining the Department of G I Surgery & Experimental Liver Transplantation as a Senior Resident.

Prof Samiran Nundy encouraged Dr Gupta to train in Liver Transplantation in the UK. Between 1993 and 1998, he trained at the Queen Elizabeth Hospital in Birmingham and at the St James University Hospital in Leeds, working closely with some of the stalwarts of Liver Transplantation, including Paul McMaster, Elwin Elias, and James Neuberger.

During his stay in the UK, Dr Gupta qualified for Fellowships at the Royal College of Surgeons of Edinburgh and Glasgow. He trained in all aspects of Liver Transplantation and was actively involved in clinical and research work as well as teaching/training junior doctors. His research on various aspects of transplantation has been published in multiple journals, presented at numerous conferences, and appreciated worldwide.

In 1998, Dr. Gupta returned to India to take up the mantle of liver transplantation in this part of the world. He was offered the Consultant in Liver Transplantation and G I Surgery position at the Sir Ganga Ram Hospital ( SGRH ) in New Delhi, which he accepted

There, he played a pioneering role in developing the first successful liver transplant program on the Indian subcontinent. While he had trained in Liver Transplantation for a long time in the UK, he also interacted with and visited several centres in Seoul, Japan, to understand the innovations that were rapidly making Living Donor Liver Transplant a successful procedure outside the Western world.

The Liver Transplant program at SGRH culminated years of preparation, aided by a few key innovations by Dr. Gupta and his colleagues. The encouraging results ensured that the program had well and truly taken off!

After the initial years at SGRH and then Indraprastha Apollo, Dr. Gupta decided that the Max Super Speciality Hospital, Saket, was better equipped to provide the infrastructure needed to sustain a busy liver transplant and HPB program.

In 2017, Dr. Subhash Gupta joined Max Super Speciality Hospital, Saket, and started the Liver Transplant & HPB program there.

Over the years, the Centre of Liver & Biliary Sciences ( CLBS ) evolved to its present shape. Today, CLBS is the busiest Living Donor Liver Transplant program globally. But Dr Gupta prides on the fact that Liver Transplantation is today only a small part of the gamut of activity that CLBS is involved in.

Although a surgeon at the core, Dr. Subhash Gupta has always believed that Liver diseases must be managed by specialists who are equally experienced in the medical & surgical aspects of treatment, the Liver Surgeon or the Medical Hepatologist in isolation cannot always judge what is in the best interests of the patient. Over the years of his vast experience, Dr Gupta has focused his clinical & research activities on managing patients with liver diseases. Liver Transplantation is the cure for only a select group of patients with Liver Diseases.

Acute Liver Failure is a disease that needs Urgent Liver Transplant when the patient’s parameters meet certain criteria. However, years of experience have demonstrated that some of these patients can be salvaged without a transplant. Having saved some of them without a transplant, Dr Gupta’s team is now focusing on validating new criteria to predict better which group of patients will inevitably need a transplant.

It is just one example among many paradigm changes in management that are the focus of his research interests.

At CLBS, Dr. Gupta continues to guide the treatment of a large number of patients with Acute or Chronic Liver Diseases, patients with Hepatitis B or C infections, those admitted with Alcoholic Steatohepatitis, as well as patients with Autoimmune Hepatitis. Children with liver diseases such as Neonatal hepatitis, Progressive Familial Intrahepatic Cholestasis ( PFIC ), Biliary atresia, Hyperoxaluria, and Wilson’s disease are also treated by the Pediatric Hepatology division at CLBS.

Tumors of the liver often present management dilemmas depending on the presentation stage. Choosing the best treatment option for a patient with Hepatocellular cancer ( HCC ) can be tricky. Oral Sorafenib, simple ablation with RFA or Alcohol injection, TACE ( Trans Arterial Chemo Embolisation ), TARE ( Trans Arterial Radio Embolisation ), Liver Resection, and Liver Transplantation are among the many treatment options available. While all these treatment modalities are available at CLBS, Dr Gupta takes a personal interest in ensuring that the patient and his family are adequately counseled and informed about the pros & cons before embarking on a particular therapy.

The common adage ‘Treat the patient, not the disease’ remains the guiding philosophy that Dr Gupta continues to train his team at CLBS.

In the field of Liver Transplant, CLBS continues to make giant strides not only in clinical care but also in leading surgical innovations in this specialty, training junior doctors in this high-end specialty, and ensuring that doctors in society become adept at treating transplanted patients in the community.

As primarily a G I Surgeon, Dr Gupta continues to treat a significant number of patients with Gastrointestinal diseases and problems of the Liver, Biliary tract, and pancreas. Liver resections, Pancreatic surgery, surgery for hydatid cysts and choledochal cysts, and surgery for Bile duct injuries are regularly performed at our centre.

While the team at CLBS continues to excel, Dr. Gupta remains a bedside clinician at its core. He ensures that he sees all patients personally, leads the surgical team during operations, and remains directly in charge of postoperative care.

Meticulous attention to detail, both inside the Operating Room and outside the ward / ICU, is the single most important reason behind the excellence in clinical care that Dr. Gupta and his team continue to provide at CLBS.

This Indian doctor is using ‘surgical strikes’ to cure Pakistan’s liver troubles. India Medical Times: Dr. Subhash Gupta